Steven Cohen’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Steven Cohen’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,805,387	Closed	-$10.1M	–	1888
2022 Q3	$10.1M	Sell	1,805,387 -83,709	-4%	-$524K	0.04%	501
2022 Q2	$8.18M	Sell	1,889,096 -80,126	-4%	-$456K	0.03%	563
2022 Q1	$22.9M	Sell	1,969,222 -132,219	-6%	-$1.57M	0.09%	294
2021 Q4	$38.4M	Buy	2,101,441 +1,601,441	+320%	+$20.3M	0.15%	179
2021 Q3	$5.92M	Buy	+500,000	New	+$7.28M	0.03%	626

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Steven Cohen's OYST Position: Q4 2022 in Review

Steven Cohen sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q4 2022, closing a stake of 1,805,387 shares — an estimated $10.1M sold.

Steven Cohen first reported a position in OYST in Q3 2021 and held it in 5 quarters. The position peaked at $38.4M in Q4 2021. 53 funds tracked by Wall St. Rank hold OYST as of Q4 2022.

Steven Cohen reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Steven Cohen sold 1,805,387 Oyster Point Pharma, Inc. Common Stock shares in Q4 2022, an estimated $10.1M.
Steven Cohen first reported a position in Oyster Point Pharma, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
Steven Cohen's Oyster Point Pharma, Inc. Common Stock position peaked at $38.4M in Q4 2021.
53 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q4 2022.

Based on Point72 Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.